ARCHIVES

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

What Research Will, Will Not Be Funded At Various Levels – FY 1997 ZBB

October 14, 1977

Cech To Step Down At HHMI In 2009.

April 18, 2008

FDA Plans Safety Reviews Of Newly Approved Drugs; Drug Safety Bills Introduced In Senate.

February 2, 2007

In Brief: Cancer Act Renewal Nears, Appropriations Bills Lag; Interim Funding Likely For ’83 Fiscal Year

September 24, 1982

Benefit Of Chemotherapy Depends ER Status

April 28, 2006

Ohio State Schedules Workshop On CCOP

February 5, 1982